Novartis loses another NIBR exec as neuro expert Shanker joins a gene therapy biotech

... is the latest R&D leader to exit the Swiss pharma giant as he takes up the helm of chief scientific officer at gene therapy startup Tevard Biosciences.
https://www.google.com/url?rct=j&sa=t&url=https://www.fiercebiotech.com/biotech/tevard-biosciences-picks-up-novartis-neuroscience-head-to-advance-gene-therapy-into-clinic&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNFUeHE-76ZTrFAhUqCOS8UkN3BTPg